UCHL1 Gene PARK5 Parkinson Genetic Test
Introduction
The UCHL1 gene is a gene that codes for the protein ubiquitin carboxyl-terminal hydrolase L1. This protein is involved in the regulation of the ubiquitin-proteasome system, which is responsible for the degradation of damaged or misfolded proteins in cells. PARK5 refers to a specific subtype of Parkinson’s disease, also known as autosomal dominant juvenile Parkinsonism. This subtype is associated with mutations in the UCHL1 gene.
Test Details
A UCHL1 gene PARK5 Parkinson NGS genetic test involves sequencing the UCHL1 gene using NGS technology to identify any mutations or variations that may be associated with Parkinson’s disease, specifically the PARK5 subtype. This test can help diagnose Parkinson’s disease and provide valuable information for personalized treatment and management of the condition.
Components and Price
Test Name: UCHL1 Gene PARK5 Parkinson Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Neurological Disorders
Doctor
Neurologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for UCHL1 Gene PARK5 Parkinson NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with UCHL1 Gene PARK5 Parkinson
Test Name | UCHL1 Gene PARK5 Parkinson Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for UCHL1 Gene PARK5 Parkinson NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with UCHL1 Gene PARK5 Parkinson |
Test Details |
The UCHL1 gene is a gene that codes for the protein ubiquitin carboxyl-terminal hydrolase L1. This protein is involved in the regulation of the ubiquitin-proteasome system, which is responsible for the degradation of damaged or misfolded proteins in cells. PARK5 refers to a specific subtype of Parkinson’s disease, also known as autosomal dominant juvenile Parkinsonism. This subtype is associated with mutations in the UCHL1 gene. NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology that allows for the rapid sequencing of large amounts of genetic material. It can be used to identify mutations or variations in genes, including the UCHL1 gene, that may be associated with Parkinson’s disease. A UCHL1 gene PARK5 Parkinson NGS genetic test involves sequencing the UCHL1 gene using NGS technology to identify any mutations or variations that may be associated with Parkinson’s disease, specifically the PARK5 subtype. This test can help diagnose Parkinson’s disease and provide valuable information for personalized treatment and management of the condition. |